Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2022 | May 04, 2022 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2022 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q1 | |
Document Transition Report | false | |
Entity File Number | 000-22904 | |
Entity Registrant Name | PARKERVISION, INC. | |
Entity Central Index Key | 0000914139 | |
Entity Incorporation, State or Country Code | FL | |
Entity Tax Identification Number | 59-2971472 | |
Entity Address, Address Line One | 4446-1A Hendricks Avenue | |
Entity Address, Address Line Two | Suite 354 | |
Entity Address, City or Town | Jacksonville | |
Entity Address, State or Province | FL | |
Entity Address, Postal Zip Code | 32207 | |
City Area Code | 904 | |
Local Phone Number | 732-6100 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Shell Company | false | |
Entity Emerging Growth Company | false | |
Entity Common Stock, Shares Outstanding | 77,935,740 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 198 | $ 1,030 |
Prepaid expenses | 463 | 574 |
Other current assets | 26 | 25 |
Total current assets | 687 | 1,629 |
Intangible assets, net | 1,696 | 1,785 |
Operating lease right-of-use assets | 7 | 7 |
Other assets, net | 17 | 19 |
Total assets | 2,407 | 3,440 |
CURRENT LIABILITIES: | ||
Accounts payable | 944 | 706 |
Accrued expenses: | ||
Salaries and wages | 43 | 27 |
Professional fees | 56 | 109 |
Other accrued expenses | 488 | 555 |
Related party note payable, current portion | 94 | 94 |
Operating lease liabilities, current portion | 116 | 155 |
Total current liabilities | 1,741 | 1,646 |
LONG-TERM LIABILITES: | ||
Secured contingent payment obligation | 36,212 | 37,372 |
Unsecured contingent payment obligations | 4,549 | 5,691 |
Convertible notes, net | 2,870 | 2,895 |
Related party note payable, net of current portion | 585 | 609 |
Operating lease liabilities, net of current portion | 3 | 4 |
Total long-term liabilities | 44,219 | 46,571 |
Total liabilities | 45,960 | 48,217 |
SHAREHOLDERS' DEFICIT: | ||
Common stock, $.01 par value, 150,000 shares authorized, 77,814 and 76,992 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively | 778 | 770 |
Additional paid-in capital | 388,749 | 387,865 |
Accumulated deficit | (433,080) | (433,412) |
Total shareholders' deficit | (43,553) | (44,777) |
Total liabilities and shareholders' deficit | $ 2,407 | $ 3,440 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Condensed Consolidated Balance Sheets [Abstract] | ||
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 150,000 | 150,000 |
Common stock, shares issued | 77,814 | 76,992 |
Common stock, shares outstanding | 77,814 | 76,992 |
Condensed Consolidated Statemen
Condensed Consolidated Statements Of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Condensed Consolidated Statements Of Comprehensive Income (Loss) [Abstract] | ||
Licensing revenue | ||
Cost of sales | (3) | |
Gross margin | (3) | |
Selling, general and administrative expenses | 1,933 | 2,280 |
Total operating expenses | 1,933 | 2,280 |
Other income | 28 | |
Interest expense | (62) | (37) |
Change in fair value of contingent payment obligations | 2,302 | (150) |
Total other income (loss), net | 2,268 | (187) |
Net income (loss) | 332 | (2,467) |
Other comprehensive income, net of tax | ||
Comprehensive income (loss) | $ 332 | $ (2,467) |
Earnings (loss) per common share: | ||
Basic | $ 0 | $ (0.04) |
Diluted | $ 0 | $ (0.04) |
Weighted average common shares outstanding: | ||
Basic | 77,553 | 63,695 |
Diluted | 106,859 | 63,695 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements Of Shareholders' Deficit - USD ($) $ in Thousands | Common Stock [Member]Cumulative Effect, Period of Adoption, Adjustment [Member] | Common Stock [Member] | Additional Paid-in Capital [Member]Cumulative Effect, Period of Adoption, Adjustment [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member]Cumulative Effect, Period of Adoption, Adjustment [Member] | Accumulated Deficit [Member] | Total |
Balance, value at Dec. 31, 2020 | $ 586 | $ (1,126) | $ 376,954 | $ 279 | $ (421,361) | $ (43,821) | |
Issuance of common stock and warrants in public and private offerings, net of issuance costs and initial fair value of contingent payment rights | 62 | 4,734 | |||||
Issuance of common stock upon exercise of options and warrants | 27 | 397 | |||||
Issuance of common stock and warrants for services | $ 6 | 391 | |||||
Issuance upon conversion | 17 | 459 | |||||
Share-based compensation, net of shares withheld for taxes | 1 | 952 | |||||
Comprehensive income (loss) for the period | (2,467) | (2,467) | |||||
Balance, value at Mar. 31, 2021 | 699 | 382,761 | (423,549) | (40,089) | |||
Balance, value at Dec. 31, 2021 | 770 | 387,865 | (433,412) | (44,777) | |||
Issuance of common stock and warrants in public and private offerings, net of issuance costs and initial fair value of contingent payment rights | (18) | ||||||
Issuance of common stock upon exercise of options and warrants | 5 | 77 | |||||
Issuance upon conversion | 3 | 79 | |||||
Share-based compensation, net of shares withheld for taxes | 746 | ||||||
Comprehensive income (loss) for the period | 332 | 332 | |||||
Balance, value at Mar. 31, 2022 | $ 778 | $ 388,749 | $ (433,080) | $ (43,553) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income (loss) | $ 332 | $ (2,467) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Depreciation and amortization | 83 | 97 |
Share-based compensation | 746 | 953 |
(Gain) loss on changes in fair value of contingent payment obligations | (2,302) | 150 |
Loss on disposal of assets | 8 | |
Changes in operating assets and liabilities: | ||
Prepaid expenses and other assets | 110 | 282 |
Accounts payable and accrued expenses | 191 | (3,970) |
Operating lease liabilities | (40) | (34) |
Total adjustments | (1,204) | (2,522) |
Net cash used in operating activities | (872) | (4,989) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchases of property and equipment | (1) | |
Net cash used in investing activities | (1) | |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Net (payments) proceeds from issuance of common stock, contingent payment rights and warrants in public and private offerings | (18) | 5,208 |
Net proceeds from exercise of options and warrants | 82 | 424 |
Principal payments on notes payable | (24) | (22) |
Net cash provided by financing activities | 40 | 5,610 |
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (832) | 620 |
CASH AND CASH EQUIVALENTS, beginning of year | 1,030 | 1,627 |
CASH AND CASH EQUIVALENTS, end of year | $ 198 | $ 2,247 |
Description Of Business
Description Of Business | 3 Months Ended |
Mar. 31, 2022 | |
Description Of Business [Abstract] | |
Description Of Business | 1. Description of Business ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH (collectively “ParkerVision”, “we” or the “Company”), is in the business of innovating fundamental wireless technologies and products. We have designed and developed proprietary radio frequency (“ RF ”) technologies and integrated circuits and license those technologies to others for use in wireless communication products. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others, and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent infringement litigation and licensing efforts. We currently have patent enforcement actions ongoing in various U.S. district courts against providers of mobile handsets, smart televisions and other WiFi products and, in certain cases, their chip suppliers for the infringement of a number of our RF patents. We have made significant investments in developing and protecting our technologies. |
Liquidity And Going Concern
Liquidity And Going Concern | 3 Months Ended |
Mar. 31, 2022 | |
Liquidity And Going Concern [Abstract] | |
Liquidity And Going Concern | 2. Liquidity and Going Concern Our accompanying condensed consolidated financial statements were prepared assuming we would continue as a going concern, which contemplates that we will continue in operation for the foreseeable future and will be able to realize assets and settle liabilities and commitments in the normal course of business for a period of at least one year from the issuance date of these condensed consolidated financial statements. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that could result should we be unable to continue as a going concern. We have incurred significant losses from operations and negative cash flows from operations in every year since inception and have utilized the proceeds from the sales of debt and equity securities and contingent funding arrangements with third parties to fund our operations, including the cost of litigation. For the three months ended March 31, 2022, we recognized net income of approximately $ 0.3 million and incurred negative cash flows from operations of approximately $ 0.9 million. At March 31, 2022, we had cash and cash equivalents of approximately $ 0.2 million and an accumulated deficit of approximately $ 433.1 million. Additionally, a significant amount of future proceeds that we may receive from our patent enforcement and licensing programs will first be utilized to repay borrowings and legal fees and expenses under our contingent funding arrangements. These circumstances raise substantial doubt about our ability to continue to operate as a going concern for a period of one year following the issue date of these condensed consolidated financial statements. In May 2022, we received proceeds of $ 0.3 million from the sale of convertible notes (see Note 14). Our current capital resources, including the proceeds from the May 2022 transaction, are not sufficient to meet our liquidity needs for the next twelve months and we will be required to seek additional capital. Our ability to meet our liquidity needs for the next twelve months is dependent upon (i) our ability to successfully negotiate licensing agreements and/or settlements relating to the use of our technologies by others in excess of our contingent payment obligations, (ii) our ability to control operating costs, and/or (iii) our ability to obtain additional debt or equity financing. We expect that proceeds received by us from patent enforcement actions and technology licenses over the next twelve months may not be sufficient to cover our working capital requirements. We expect to continue to invest in the support of our patent enforcement and licensing programs. The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from our technologies and/or products to offset expenses and contingent payment obligations. In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private debt or equity financing or contingent fee arrangements and/or reduce operating costs. Failure to generate sufficient revenues, raise additional capital through debt or equity financings or contingent fee arrangements, and/or reduce operating costs will have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives. |
Basis Of Presentation
Basis Of Presentation | 3 Months Ended |
Mar. 31, 2022 | |
Basis Of Presentation [Abstract] | |
Basis Of Presentation | 3. Basis of Presentation The accompanying unaudited condensed consolidated financial statements for the period ended March 31, 2022 were prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Operating results for the three months ended March 31, 2022, are not necessarily indicative of the results that may be expected for the year ending December 31, 2022, or future years. All normal and recurring adjustments which, in the opinion of management, are necessary for a fair statement of the consolidated financial condition and results of operations have been included. The year-end condensed consolidated balance sheet data was derived from audited financial statements for the year ended December 31, 2021. C ertain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with GAAP have been omitted from these interim condensed consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with our latest Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Annual Report”). The condensed consolidated financial statements include the accounts of ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH, after elimination of all intercompany transactions and accounts. |
Accounting Policies
Accounting Policies | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Accounting Policies | 4. Accounting Policies There have been no changes in accounting policies from those stated in our 2021 Annual Report. We do not expect any newly effective accounting standards to have a material impact on our financial position, results of operations or cash flows when they become effective. |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2022 | |
Revenue [Abstract] | |
Revenue | 5. Revenue We have an active monitoring and enforcement program with respect to our intellectual property rights that includes seeking appropriate compensation from third parties that utilize or have utilized our intellectual property without a license. As a result, we may receive payments as part of a settlement or in the form of court-awarded damages for a patent infringement dispute. We recognize such payments as revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” No revenue was recognized during the three-month periods ended March 31, 2022 or 2021. |
Earnings (Loss) per Common Shar
Earnings (Loss) per Common Share | 3 Months Ended |
Mar. 31, 2022 | |
Earnings (Loss) per Common Share [Abstract] | |
Earnings (Loss) per Common Share | 6. Earnings (Loss) per Common Share Basic earnings (loss) per common share is determined based on the weighted-average number of common shares outstanding during each period. The dilutive effect of outstanding options and warrants is calculated using the treasury stock method. The dilutive effect of shares underlying convertible notes was calculated using the if-converted method. The following table shows the computation of basic and diluted earnings (loss) per share for the three months ended March 31, 2022 and 2021 (net income and shares in thousands): March 31, 2022 2021 Numerator: Net income (loss) $ 332 $ ( 2,467 ) Effect of dilutive securities 56 - Net income (loss) adjusted for dilutive effect $ 388 $ ( 2,467 ) Denominator: Weighted-average basic shares outstanding 77,553 63,695 Effect of dilutive securities 29,306 - Weighted-average diluted shares 106,859 63,695 Basic earnings (loss) per share $ 0.00 $ ( 0.04 ) Diluted earnings (loss) per share $ 0.00 $ ( 0.04 ) Diluted earnings (loss) per common share for the three months ended March 31, 2022 excludes options and warrants that are anti-dilutive. For the three months ended March 31, 2021, all shares underlying outstanding options, warrants, unvested restricted stock units (“RSUs”) and convertible notes were excluded from the computation of diluted loss per share as their effect would have been anti-dilutive. The anti-dilutive common share equivalents at March 31, 2022 and 2021 were as follows (in thousands): March 31, 2022 2021 Options outstanding 373 24,875 Warrants outstanding 7,346 12,169 Unvested RSUs - 85 Shares underlying convertible notes - 21,957 7,719 59,086 |
Prepaid Expenses
Prepaid Expenses | 3 Months Ended |
Mar. 31, 2022 | |
Prepaid Expenses [Abstract] | |
Prepaid Expenses | 7. Prepaid Expenses Prepaid expenses consist of the following (in thousands): March 31, December 31, 2022 2021 Prepaid services $ 400 $ 523 Prepaid insurance 30 16 Prepaid licenses, software tools and support 23 23 Other prepaid expenses 10 12 $ 463 $ 574 Prepaid services at March 31, 2022 and December 31, 2021 include approximately $ 0.4 million and $ 0.5 million, respectively of consulting services paid in shares of stock or warrants to purchase shares of stock in the future. |
Intangible Assets
Intangible Assets | 3 Months Ended |
Mar. 31, 2022 | |
Intangible Assets [Abstract] | |
Intangible Assets | 8. Intangible Assets Intangible assets consist of the following (in thousands): March 31, December 31, 2022 2021 Patents and copyrights $ 14,683 $ 14,755 Accumulated amortization ( 12,987 ) ( 12,970 ) $ 1,696 $ 1,785 |
Debt
Debt | 3 Months Ended |
Mar. 31, 2022 | |
Debt [Abstract] | |
Debt | 9. Debt Notes Payable Related Party Note Payable We have an unsecured promissory note of approximately $ 0.7 million payable to Sterne, Kessler, Goldstein, & Fox, PLLC (“SKGF”), a related party, for outstanding unpaid fees for legal services. The note, as amended, accrues interest at a rate of 4 % per annum and provides for monthly payments of principal and interest of $ 10,000 with a final balloon payment of approximately $ 0.59 million due at the maturity date of April 30, 2023. We are currently in compliance with all the terms of the note. Convertible Notes Our convertible notes represent 5 -year promissory notes that are convertible, at the holders’ option, into shares of our common stock at fixed conversion prices. Interest payments are made on a quarterly basis and are payable, at our option, subject to certain equity conditions, in either cash, shares of our common stock, or a combination thereof. The number of shares issued for interest is determined by dividing the interest payment amount by the closing price of our common stock on the trading day immediately prior to the scheduled interest payment date. To date, all interest payments on the convertible notes have been made in shares of our common stock. We have recognized the convertible notes as debt in our condensed consolidated financial statements. We have the option to prepay the majority of the notes, subject to a premium on the outstanding principal prepayment amount of 25 % prior to the two-year anniversary of the note issuance date, 20 % prior to the three-year anniversary of the note issuance date, 15 % prior to the four-year anniversary of the note issuance date, or 10 % thereafter. The notes provide for events of default that include failure to pay principal or interest when due, breach of any of the representations, warranties, covenants or agreements made by us, events of liquidation or bankruptcy, and a change in control. In the event of default, the interest rate increases to 12 % per annum and the outstanding principal balance of the notes plus all accrued interest due may be declared immediately payable by the holders of a majority of the then outstanding principal balance of the notes. Convertible notes payable at March 31, 2022 and December 31, 2021 consist of the following (in thousands): Fixed Principal Outstanding as of Conversion Interest March 31, December 31, Description Rate Rate Maturity Date 2022 2021 Convertible notes dated September 10, 2018 $ 0.40 8.0 % September 10, 2023 $ 200 $ 200 Convertible note dated September 19, 2018 $ 0.57 8.0 % September 19, 2023 425 425 Convertible notes dated February/March 2019 $ 0.25 8.0 % February 28, 2024 to March 13, 2024 750 750 Convertible notes dated June/July 2019 $ 0.10 8.0 % June 7, 2024 to July 15, 2024 295 320 Convertible notes dated July 18, 2019 $ 0.08 7.5 % July 18, 2024 700 700 Convertible notes dated September 13, 2019 $ 0.10 8.0 % September 13, 2024 50 50 Convertible notes dated January 8, 2020 $ 0.13 8.0 % January 8, 2025 1 450 450 Total principal balance $ 2,870 $ 2,895 1 The maturity date may be extended by one-year increments for up to an additional five years at the holders’ option at a reduced interest rate of 2 %. For the three months ended March 31, 2022, convertible notes with a face value of $ 0.03 million were converted, at the option of the holders, into 250,000 shares of our common stock and we recognized interest expense of approximately $ 0.06 million related to the contractual interest which we elected to pay in shares of our common stock. For the three months ended March 31, 2022, we issued approximately 92,000 shares of our common stock as interest-in-kind payments on our convertible notes. At March 31, 2022, we estimate our convertible notes have an aggregate fair value of approximately $ 2.3 million and would be categorized within Level 2 of the fair value hierarchy. Secured Contingent Payment Obligation The following table provides a reconciliation of our secured contingent payment obligation, measured at estimated fair market value, for the three months ended March 31, 2022 and the year ended December 31, 2021 (in thousands) : Three Months Ended March 31, 2022 Year Ended December 31, 2021 Secured contingent payment obligation, beginning of period $ 37,372 $ 33,057 Change in fair value ( 1,160 ) 4,315 Secured contingent payment obligation, end of period $ 36,212 $ 37,372 Our secured contingent payment obligation represents the estimated fair value of our repayment obligation to Brickell Key Investments, LP (“Brickell”) under a February 2016 funding agreement, as amended. Brickell is entitled to priority payments of 52 % to 100 % of proceeds received from all patent-related actions until such time that Brickell has been repaid its minimum return. The minimum return is determined as a multiple of the funded amount that increases over time. The estimated minimum return due to Brickell was approximately $ 50.5 million and $ 48.8 million as of March 31, 2022 and December 31, 2021, respectively. In addition, Brickell is entitled to a pro rata portion of proceeds from specified legal actions to the extent aggregate proceeds from those actions exceed the minimum return. The range of potential proceeds payable to Brickell is discussed more fully in Note 10. As of March 31, 2022, we are in compliance with our obligations under this agreement. We have elected to measure our secured contingent payment obligation at its estimated fair value based on probability-weighted estimated cash outflows, discounted back to present value using a discount rate determined in accordance with accepted valuation methods (see Note 10). The secured contingent payment obligation is remeasured to fair value at each reporting period with changes recorded in the condensed consolidated statements of comprehensive income (loss) until the contingency is resolved. Unsecured Contingent Payment Obligations The following table provides a reconciliation of our unsecured contingent payment obligations, measured at estimated fair market value, for the three months ended March 31, 2022 and the year ended December 31, 2021 (in thousands) : Three Months Ended March 31, 2022 Year Ended December 31, 2021 Unsecured contingent payment obligations, beginning of period $ 5,691 $ 5,222 Issuance of contingent payment rights - 412 Change in fair value ( 1,142 ) 57 Unsecured contingent payment obligations, end of period $ 4,549 $ 5,691 Our unsecured contingent payment obligations represent amounts payable to others from future patent-related proceeds including (i) a termination fee due to a litigation funder and (ii) contingent payment rights issued to accredited investors in connection with equity financings (“CPRs”). We have elected to measure these unsecured contingent payment obligations at their estimated fair value based on probability-weighted estimated cash outflows, discounted back to present value using a discount rate determined in accordance with accepted valuation methods. The unsecured contingent payment obligations will be remeasured to fair value at each reporting period with changes recorded in the condensed consolidated statements of comprehensive income (loss) until the contingency is resolved (see Note 10). |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Measurements [Abstract] | |
Fair Value Measurements | 10. Fa ir Value Measurements The following tables summarize the fair value of our assets and liabilities measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 (in thousands): Fair Value Measurements Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) March 31, 2022: Liabilities: Secured contingent payment obligation $ 36,212 $ - $ - $ 36,212 Unsecured contingent payment obligations 4,549 - - 4,549 Fair Value Measurements Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) December 31, 2021: Liabilities: Secured contingent payment obligation $ 37,372 $ - $ - $ 37,372 Unsecured contingent payment obligations 5,691 - - 5,691 The fair values of our secured and unsecured contingent payment obligations were estimated using a probability-weighted income approach based on various cash flow scenarios as to the outcome of patent-related actions both in terms of timing and amount, discounted to present value using a risk-adjusted rate. We used a risk-adjusted discount rate of 16.36 % at March 31, 2022, based on a risk-free rate of 2.36 % as adjusted by 8 % for credit risk and 6 % for litigation inherent risk. The following table provides quantitative information about the significant unobservable inputs used in the measurement of fair value for both the secured and unsecured contingent payment obligations at March 31, 2022, including the lowest and highest undiscounted payout scenarios as well as a weighted average payout scenario based on relative undiscounted fair value of each cash flow scenario. Secured Contingent Payment Obligation Unsecured Contingent Payment Obligations Unobservable Inputs Low Weighted Average High Low Weighted Average High Estimated undiscounted cash outflows (in millions) $ 0.0 59.4 88.4 $ 0.0 $ 7.5 $ 10.8 Duration (in years) 1.5 2.9 3.5 1.5 3.0 3.5 Estimated probabilities 5 % 17 % 35 % 5 % 18 % 35 % We evaluate the estimates and assumptions used in determining the fair value of our contingent payment obligations each reporting period and make any adjustments prospectively based on those evaluations. Changes in any of these Level 3 inputs could result in a significantly higher or lower fair value measurement. |
Legal Proceedings
Legal Proceedings | 3 Months Ended |
Mar. 31, 2022 | |
Legal Proceedings [Abstract] | |
Legal Proceedings | 11. Legal Proceedings From time to time, we are subject to legal proceedings and claims which arise in the ordinary course of our business. These proceedings include patent enforcement actions initiated by us against others for the infringement of our technologies, as well as proceedings brought by others against us, including proceedings at the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (“PTAB”). The majority of our litigation, including our PTAB proceedings, is being paid for through contingency fee arrangements with our litigation counsel as well as third-party litigation financing. In general, litigation counsel is entitled to recoup on a priority basis, from litigation proceeds, any out-of-pocket expenses incurred. Following reimbursement of out-of-pocket expenses, litigation counsel is generally entitled to a percentage of remaining proceeds based on the terms of the specific arrangement between us, counsel and our third-party litigation funder. ParkerVision v. Qualcomm (Middle District of Florida-Orlando Division) We have filed a notice of appeal of a summary judgment decision issued in March 2022 by the Middle District of Florida in our patent infringement complaint against Qualcomm Incorporated and Qualcomm Atheros, Inc. (collectively “Qualcomm”). The patent infringement case was filed in the Middle District of Florida in May 2014. The case was stayed in February 2016 pending decisions in other cases, including the appeal of a PTAB proceeding with regard to U.S. patent 6,091,940 (“the ‘940 Patent”) asserted in this case. In March 2017, the PTAB ruled in our favor on three of the six petitions (the method claims), ruled in Qualcomm’s favor on two of the six petitions (the apparatus claims) and issued a split decision on the claims covered in the sixth petition. In September 2018, the Federal Circuit upheld the PTAB’s decision with regard to the ‘940 Patent and, in January 2019, the court lifted the stay in this case. In July 2019, the court issued an order that granted our proposed selection of patent claims from four asserted patents, including the ‘940 Patent, and denied Qualcomm’s request to limit the claims and patents. The court also agreed that we may elect to pursue accused products that were at issue at the time the case was stayed, as well as new products that were released by Qualcomm during the pendency of the stay. In September 2019, Qualcomm filed a motion for partial summary judgment in an attempt to exclude certain patents from the case, including the ‘940 Patent. The court denied this motion in January 2020. In April 2020, the court issued its claim construction order in which the court adopted our proposed construction for seven of the ten disputed terms and adopted slightly modified versions of our proposed construction for the remaining terms. Due to the impact of COVID-19, a number of the scheduled deadlines in this case were moved including the trial commencement date which was rescheduled from December 2020 to May 2021. In October 2020, our damages expert submitted a report supporting our damages ask of $ 1.3 billion for Qualcomm’s unauthorized use of our technology. Such amount excludes additional amounts requested by us for interest and enhanced damages for willful infringement. Ultimately, the amount of damages, if any, will be determined by the court. Discovery was expected to close in December 2020; however, the court allowed us to designate a substitute expert due to medical issues with one of our experts in the case. Accordingly, the close of discovery was delayed until January 2021. As a result of these delays, the court rescheduled the trial commencement date from May 3, 2021 to July 6, 2021. In March 2021, the court further delayed the trial date citing backlog due to the pandemic, among other factors. A new trial date was not set and the court indicated the case was unlikely to be tried before November or December 2021. Fact and expert discovery has been completed, expert reports have been submitted, and summary judgment and Daubert briefings were submitted by the parties. Joint pre-trial statements were submitted in May 2021. In March 2021, the court granted Qualcomm’s motion to strike certain of our 2020 infringement contentions. As a result of this ruling, in July 2021, we filed a joint motion for entry of a judgment of non-infringement of our Patent No. 7,865,177 (“the ‘177 Patent”), subject to appeal. In January 2022, the court held a hearing to allow the parties to present their respective positions on three outstanding motions. The court indicated that upon its ruling on these motions, a pre-trial conference would be scheduled and a trial date set. On March 9, 2022, the court ruled with respect to one of these motions granting Qualcomm’s motion to strike and exclude opinions regarding the alleged infringement and validity issues. This court order precluded the presentation of infringement and validity opinions by both of our experts at trial. On March 22, 2022, the court issued an order granting Qualcomm’s motion for summary judgment ruling that Qualcomm does not infringe the remaining three patents in this case. On April 20, 2022, we filed a notice of appeal to the United States Court of Appeals for the Federal Circuit. As a result of the court’s summary judgment motion in favor of Qualcomm, Qualcomm has the right to petition the court for its fees and costs. The court has granted a Qualcomm motion to delay such a petition until 30 days following the appellate court’s decision. We are represented in this case on a full contingency fee basis. ParkerVision v. Apple and Qualcomm (Middle District of Florida-Jacksonville Division) In December 2015, we filed a patent infringement complaint in the Middle District of Florida against Apple Inc. (“Apple”), LG Electronics, Inc., LG Electronics U.S.A., Inc. and LG Electronics MobileComm U.S.A., Inc. (collectively “LG”), Samsung Electronics Co. Ltd., Samsung Electronics America, Inc., Samsung Telecommunications America LLC, and Samsung Semiconductor, Inc. (collectively “Samsung”), and Qualcomm alleging infringement of four of our patents. In February 2016, the district court proceedings were stayed pending resolution of a corresponding case filed at the International Trade Commission (“ITC”). In July 2016, we entered into a patent license and settlement agreement with Samsung and, as a result, Samsung was dismissed from the district court action. In March 2017, we filed a motion to terminate the ITC proceedings and a corresponding motion to lift the stay in the district court case. This motion was granted in May 2017. In July 2017, we filed a motion to dismiss LG from the district court case and re-filed our claims against LG in the District of New Jersey (see ParkerVision v. LG below). Also in July 2017, Qualcomm filed a motion to change venue to the Southern District of California, and Apple filed a motion to dismiss for improper venue. In March 2018, the district court ruled against the Qualcomm and Apple motions. The parties also filed a joint motion in March 2018 to eliminate three of the four patents in the case in order to expedite proceedings leaving our U.S. patent 9,118,528 as the only remaining patent in this case. A claim construction hearing was held on August 31, 2018. In July 2019, the court issued its claim construction order in which the court adopted our proposed claim construction for two of the six terms and the “plain and ordinary meaning” on the remaining terms. In addition, the court denied a motion filed by Apple for summary judgment. Fact discovery has closed in this case and a jury trial was scheduled to begin in August 2020. In March 2020, as a result of the impact of COVID-19, the parties filed a motion requesting an extension of certain deadlines in the case. In April 2020, the court stayed this proceeding pending the outcome of the infringement case against Qualcomm in the Orlando Division of the Middle District of Florida, which is currently pending an appeal. ParkerVision v. LG (District of New Jersey) In July 2017, we filed a patent infringement complaint in the District of New Jersey against LG for the alleged infringement of the same four patents previously asserted against LG in the Middle District of Florida (see ParkerVision v. Apple and Qualcomm above). We elected to dismiss the case in the Middle District of Florida and re-file in New Jersey as a result of a Supreme Court ruling regarding proper venue. In March 2018, the court stayed this case pending a final decision in ParkerVision v. Apple and Qualcomm in the Middle District of Florida. As part of this stay, LG has agreed to be bound by the final claim construction decision in that case. ParkerVision v. Intel (Western District of Texas) In February 2020, we filed a patent infringement complaint in the Western District of Texas against Intel Corporation (“Intel”) alleging infringement of eight of our patents. The complaint was amended in May 2020 to add two additional patents. In June 2020, we requested that one of the patents be dropped from this case and filed a second case in the Western District of Texas that included this dismissed patent (see ParkerVision v. Intel II below). Intel’s response to our complaint was filed in June 2020 denying infringement and claiming invalidity of the patents. Intel also filed a motion to transfer venue which was denied by the court. In July 2020 and September 2020, Intel filed petitions for Inter Partes Review (“ IPR”) against two of the patents in this case and in January 2021, the PTAB instituted proceedings with regard to these two petitions (see Intel v. ParkerVision (PTAB) below). The court issued its claim construction ruling in January 2021 in which the majority of the claims were decided in our favor. The case was scheduled for trial beginning February 7, 2022. In April 2021, we filed an amended complaint to include additional Intel chips and products, including WiFi devices, to the complaint. The court suggested that, given the number of patents at issue, the case would be separated into two trials and, as a result of the added products, the first trial date was scheduled for June 2022. In January 2022, the PTAB issued its ruling on the IPRs (see Intel v. ParkerVision (PTAB) below). In February 2022, the parties filed a joint motion with respect to both Intel cases whereby the first case would be narrowed to six total patents asserted against Intel cellular products. These same six patents would be also asserted in the second Intel case, along with one additional patent from the second case, against Intel WiFi and Bluetooth products. As a result of the restructuring of the two cases, the trial date was moved to October 2022. In March 2022, due to discovery delays, the court agreed to move the trial commencement date to December 5, 2022. Discovery is ongoing in this case. In March 2022, Intel filed a motion requesting further claim construction which we have opposed. The court has not yet ruled on this motion. In May 2022, we filed a motion to amend our complaint to add willful infringement based on information obtained during discovery. We are represented in this case on a full contingency fee basis. ParkerVision v. Intel II (Western District of Texas) In June 2020, to reduce the number of claims in ParkerVision v. Intel , we filed a second patent infringement complaint in the Western District of Texas against Intel that included one patent that we voluntarily dismissed from the original case. In July 2020, we amended our complaint adding two more patents to the case. Intel responded to the complaint denying infringement and claiming invalidity of the patents. In January 2021, Intel filed a petition for IPR against one of the patents in this case and in July 2021, the PTAB instituted proceedings with regard to this petition (see Intel v. ParkerVision (PTAB) below). We filed an amended complaint in 2021 adding Intel WiFi and Bluetooth products to the case. Two claim construction hearings were held in June 2021 and July 2021 and the court’s claim construction ruling was largely decided in our favor. The case was scheduled for trial in October 2022. In February 2022, the parties filed a joint motion which provided that the Intel II case would assert the same six patents from the first Intel case, provided none of the patents were invalidated in the first case, as well as one additional patent, depending on the outcome of the pending IPR proceeding. As a result of the restructuring of the cases, we anticipate the trial will be scheduled for this case in the fall of 2023. We are represented in this case on a full contingency fee basis. Intel v. ParkerVision (PTAB) Intel filed IPR petitions against U.S. patent 7,539,474 (“the ‘474 Patent”) and U.S. patent 7,110,444 (“the ‘444 Patent”) which were both asserted in ParkerVision v. Intel . Intel also filed a petition for IPR against U.S. patent 8,190,108 (“the ‘108 Patent”),which is asserted in ParkerVision v. Intel II . In January 2021, the PTAB issued its decision to institute IPR proceedings for the ‘444 Patent and the ‘474 Patent. An oral hearing was held on November 1, 2021 and final decisions from the PTAB on the ‘474 Patent and the ‘444 Patent were issued in January 2022. The PTAB ruled against us with respect to the single challenged claim of the ’444 Patent and ruled in our favor with respect to the seven challenged claims of the ‘474 Patent. The ‘444 Patent has subsequently been excluded from the narrowed claims asserted in ParkerVision v. Intel . In July 2021, the PTAB issued its decision to institute IPR proceedings for the ‘108 Patent. We filed our response to this petition in October 2021 and an oral hearing was held on April 26, 2022. A final decision from the PTAB with respect to the ‘108 Patent is expected by July 2022. Depending on the PTAB’s ruling with respect to the ‘108 Patent, we have the option to include or exclude this patent from the patents being asserted in the Intel II case. Additional Patent Infringement Cases – Western District of Texas ParkerVision filed a number of additional patent cases in the Western District of Texas in September and October 2020 including cases against (i) TCL Industries Holdings Co., Ltd, a Chinese company, TCL Electronics Holdings Ltd., Shenzhen TCL New Technology Co., Ltd, TCL King Electrical Appliances (Huizhou) Co., Ltd., TCL Moka Int’l Ltd. and TCL Moka Manufacturing S.A. DE C.V. (collectively “TCL”), (ii) Hisense Co., Ltd. and Hisense Visual Technology Co., Ltd (collectively “Hisense”), a Chinese company, (iii) Buffalo Inc., a Japanese company (“Buffalo”) and (iv) Zyxel Communications Corporation, a Chinese multinational electronics company headquartered in Taiwan, (“Zyxel”). Each case alleges infringement of the same ten patents by products that incorporate modules containing certain WiFi chips manufactured by Realtek and/or MediaTek. Each of the defendants have filed responses denying infringement and claiming invalidity of the patents, among other defenses. In May 2021, we also filed a patent infringement case against LG Electronics, a South Korean company, in the Western District of Texas alleging infringement of the same ten patents. In September 2021, we dismissed the cases against Buffalo and Zyxel following satisfaction of the parties’ obligations under settlement and license agreements entered into in May 2021 and September 2021, respectively. In May 2021, TCL and Hisense filed petitions for IPR against two of the ten patents asserted against them, including the ‘444 Patent which was challenged by Intel (see TCL, et. al. v. ParkerVision (PTAB) below). In December 2021, LGE filed nearly identical petitions for IPR against the same two patents along with a joinder motion requesting to join the existing petitions. The court held a combined Markman hearing on October 27, 2021 for the cases against Hisense and TCL. The court issued its claim construction recommendations on October 29, 2021, in which nearly all of the claim terms were decided in our favor. The Hisense and TCL cases currently have a trial date scheduled for December 12, 2022. A claim construction hearing for the LGE case is scheduled for May 2022, with a trial scheduled to commence on April 24, 2023. We are represented in each of these cases on a full contingency fee basis. TCL, et. al. v. ParkerVision (PTAB) In May 2021, TCL, along with Hisense, filed petitions for IPR against U.S. patent 7,292,835 (“the ‘835 Patent”) and the ‘444 Patent, both of which are asserted in the infringement cases against these parties in the Western District of Texas. In November 2021, the PTAB issued its decision to implement IPR proceedings for these two patents. In December 2021, LGE filed nearly identical petitions against the same two patents along with a joinder motion requesting to join the existing petitions filed by TCL and Hisense. In April 2022, the PTAB granted LGE’s joinder motion. Oral hearings are scheduled for these IPRs in September 2022 with a final decision expected in November 2022. |
Stock Authorization and Issuanc
Stock Authorization and Issuance | 3 Months Ended |
Mar. 31, 2022 | |
Stock Authorization and Issuance [Abstract] | |
Stock Authorization and Issuance | 12. Stock Authorization and Issuance Common Stock Warrants As of March 31, 2022, we had outstanding warrants for the purchase of up to 10.3 million shares of our common stock. The estimated grant date fair value of these warrants of $ 3.2 million is included in additional paid-in capital in our condensed consolidated balance sheets. As of March 31, 2022, our outstanding warrants have an average exercise price of $ 0.75 per share and a weighted average remaining life of approximately 2.8 years. |
Share-Based Compensation
Share-Based Compensation | 3 Months Ended |
Mar. 31, 2022 | |
Share-Based Compensation [Abstract] | |
Share-Based Compensation | 13. Share-Based Compensation There has been no material change in the assumptions used to compute the fair value of our equity awards, nor in the method used to account for share-based compensation from those stated in our 2021 Annual Report. For the three months ended March 31, 2022 and 2021, we recognized share-based compensation expense of approximately $ 0.75 million and $ 0.95 million, respectively. Share-based compensation is included in selling, general and administrative expenses in the accompanying condensed, consolidated statements of comprehensive income (loss). As of March 31, 2022, there was $ 2.2 million of total unrecognized compensation cost related to all non-vested share-based compensation awards. The cost is expected to be recognized over a weighted-average remaining life of approximately 0.75 years. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | 14. Subsequent Events On May 10, 2022, we received proceeds of $ 0.3 million from the sale of convertible notes to accredited investors, including Paul Rosenbaum, one of our directors. The notes mature five years from the date of issuance and are convertible, at the holders’ option, into shares of our common stock at a fixed conversion price of $ 0.13 per share. The notes bear interest at a stated rate of 8 % per annum. Interest is payable quarterly, and we may elect, subject to certain equity conditions, to pay interest in cash, shares of our common stock, or a combination thereof. We also entered into a registration rights agreement with the investors pursuant to which we will register the shares underlying the notes. We have committed to file the registration statement by the 90 th calendar day following the closing date and to cause the registration statement to become effective by the 120 th calendar day following the closing date. The registration rights agreement provides for liquidated damages upon the occurrence of certain events, including failure by us to file the registration statement or cause it to become effective by the deadlines set forth above. The amount of liquidated damages is 1.0 % of the aggregate subscription upon the occurrence of the event, and monthly thereafter, up to a maximum of 6 %, or $ 0.02 million. |
Earnings (Loss) per Common Sh_2
Earnings (Loss) per Common Share (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Earnings (Loss) per Common Share [Abstract] | |
Earnings (Loss) Per Share | March 31, 2022 2021 Numerator: Net income (loss) $ 332 $ ( 2,467 ) Effect of dilutive securities 56 - Net income (loss) adjusted for dilutive effect $ 388 $ ( 2,467 ) Denominator: Weighted-average basic shares outstanding 77,553 63,695 Effect of dilutive securities 29,306 - Weighted-average diluted shares 106,859 63,695 Basic earnings (loss) per share $ 0.00 $ ( 0.04 ) Diluted earnings (loss) per share $ 0.00 $ ( 0.04 ) |
Summary Of Anti-Dilutive Shares | March 31, 2022 2021 Options outstanding 373 24,875 Warrants outstanding 7,346 12,169 Unvested RSUs - 85 Shares underlying convertible notes - 21,957 7,719 59,086 |
Prepaid Expenses (Tables)
Prepaid Expenses (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Prepaid Expenses [Abstract] | |
Schedule Of Prepaid Expenses | March 31, December 31, 2022 2021 Prepaid services $ 400 $ 523 Prepaid insurance 30 16 Prepaid licenses, software tools and support 23 23 Other prepaid expenses 10 12 $ 463 $ 574 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Intangible Assets [Abstract] | |
Schedule Of Intangible Assets | March 31, December 31, 2022 2021 Patents and copyrights $ 14,683 $ 14,755 Accumulated amortization ( 12,987 ) ( 12,970 ) $ 1,696 $ 1,785 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Debt Instrument [Line Items] | |
Schedule Of Convertible Notes Payable | Fixed Principal Outstanding as of Conversion Interest March 31, December 31, Description Rate Rate Maturity Date 2022 2021 Convertible notes dated September 10, 2018 $ 0.40 8.0 % September 10, 2023 $ 200 $ 200 Convertible note dated September 19, 2018 $ 0.57 8.0 % September 19, 2023 425 425 Convertible notes dated February/March 2019 $ 0.25 8.0 % February 28, 2024 to March 13, 2024 750 750 Convertible notes dated June/July 2019 $ 0.10 8.0 % June 7, 2024 to July 15, 2024 295 320 Convertible notes dated July 18, 2019 $ 0.08 7.5 % July 18, 2024 700 700 Convertible notes dated September 13, 2019 $ 0.10 8.0 % September 13, 2024 50 50 Convertible notes dated January 8, 2020 $ 0.13 8.0 % January 8, 2025 1 450 450 Total principal balance $ 2,870 $ 2,895 |
Secured Debt [Member] | |
Debt Instrument [Line Items] | |
Reconciliation Of Secured And Unsecured Contingent Obligation At Fair Value | Three Months Ended March 31, 2022 Year Ended December 31, 2021 Secured contingent payment obligation, beginning of period $ 37,372 $ 33,057 Change in fair value ( 1,160 ) 4,315 Secured contingent payment obligation, end of period $ 36,212 $ 37,372 |
Unsecured Debt [Member] | |
Debt Instrument [Line Items] | |
Reconciliation Of Secured And Unsecured Contingent Obligation At Fair Value | Three Months Ended March 31, 2022 Year Ended December 31, 2021 Unsecured contingent payment obligations, beginning of period $ 5,691 $ 5,222 Issuance of contingent payment rights - 412 Change in fair value ( 1,142 ) 57 Unsecured contingent payment obligations, end of period $ 4,549 $ 5,691 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Measurements [Abstract] | |
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis | Fair Value Measurements Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) March 31, 2022: Liabilities: Secured contingent payment obligation $ 36,212 $ - $ - $ 36,212 Unsecured contingent payment obligations 4,549 - - 4,549 Fair Value Measurements Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) December 31, 2021: Liabilities: Secured contingent payment obligation $ 37,372 $ - $ - $ 37,372 Unsecured contingent payment obligations 5,691 - - 5,691 |
Quantitative Information | Secured Contingent Payment Obligation Unsecured Contingent Payment Obligations Unobservable Inputs Low Weighted Average High Low Weighted Average High Estimated undiscounted cash outflows (in millions) $ 0.0 59.4 88.4 $ 0.0 $ 7.5 $ 10.8 Duration (in years) 1.5 2.9 3.5 1.5 3.0 3.5 Estimated probabilities 5 % 17 % 35 % 5 % 18 % 35 % |
Liquidity And Going Concern (De
Liquidity And Going Concern (Details) - USD ($) $ in Thousands | May 09, 2022 | Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 |
Liquidity And Working Capital [Line Items] | ||||
Net income (loss) | $ 332 | $ (2,467) | ||
Net cash used in operating activities | (872) | $ (4,989) | ||
Accumulated deficit | (433,080) | $ (433,412) | ||
Cash and cash equivalents | $ 198 | $ 1,030 | ||
Subsequent Event [Member] | Convertible Debt [Member] | ||||
Liquidity And Working Capital [Line Items] | ||||
Proceeds from debt | $ 300 |
Revenue (Details)
Revenue (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Revenue [Abstract] | ||
Contract with Customer, Liability, Revenue Recognized | $ 0 | $ 0 |
Earnings (Loss) per Common Sh_3
Earnings (Loss) per Common Share (Earnings (Loss) Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Numerator [Abstract] | ||
Net income (loss) | $ 332 | $ (2,467) |
Dilutive Securities, Effect on Basic Earnings Per Share | 56 | |
Net Income (Loss) Attributable to Parent, Diluted, Total | $ 388 | $ (2,467) |
Denominator [Abstract] | ||
Weighted Average Number of Shares Outstanding, Basic | 77,553 | 63,695 |
Weighted Average Number Diluted Shares Outstanding Adjustment | 29,306 | |
Weighted Average Number of Shares Outstanding, Diluted, Total | 106,859 | 63,695 |
Earnings Per Share, Basic | $ 0 | $ (0.04) |
Earnings Per Share, Diluted | $ 0 | $ (0.04) |
Earnings (Loss) per Common Sh_4
Earnings (Loss) per Common Share (Summary Of Anti-Dilutive Shares) (Details) - shares shares in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation of diluted loss per share | 7,719 | 59,086 |
Stock Options [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation of diluted loss per share | 373 | 24,875 |
Warrants Outstanding [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation of diluted loss per share | 7,346 | 12,169 |
Restricted Stock Units (RSUs) [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation of diluted loss per share | 85 | |
Convertible Debt Securities [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation of diluted loss per share | 21,957 |
Prepaid Expenses (Narrative) (D
Prepaid Expenses (Narrative) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Prepaid Expenses [Abstract] | ||
Consulting services | $ 0.4 | $ 0.5 |
Prepaid Expenses (Schedule Of P
Prepaid Expenses (Schedule Of Prepaid Expenses) (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Prepaid Expenses [Abstract] | ||
Prepaid services | $ 400 | $ 523 |
Prepaid licenses, software tools and support | 30 | 16 |
Prepaid insurance | 23 | 23 |
Other prepaid expenses | 10 | 12 |
Prepaid expenses | $ 463 | $ 574 |
Intangible Assets (Details)
Intangible Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Intangible Assets [Abstract] | ||
Patents and copyrights | $ 14,683 | $ 14,755 |
Accumulated amortization | (12,987) | (12,970) |
Total | $ 1,696 | $ 1,785 |
Debt (Narrative) (Details)
Debt (Narrative) (Details) | May 09, 2022USD ($)$ / shares | Mar. 31, 2022USD ($)itemshares | Mar. 31, 2021USD ($) | Dec. 31, 2021USD ($) |
Debt Instrument [Line Items] | ||||
Contingent Payment Obligation, Minimum Return | $ 50,500,000 | $ 48,800,000 | ||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) | $ 2,302,000 | $ (150,000) | ||
Convertible Debt [Member] | ||||
Debt Instrument [Line Items] | ||||
Interest rate | 12.00% | |||
Interest expense | $ 60,000 | |||
Outstanding principal converted | $ 30,000 | |||
Shares issued | shares | 250,000 | |||
Aggregate common stock | item | 92,000 | |||
Debt, term | 5 years | |||
Convertible Debt [Member] | Debt Instrument, Redemption, Period One [Member] | ||||
Debt Instrument [Line Items] | ||||
Principal prepayment | 25.00% | |||
Convertible Debt [Member] | Debt Instrument, Redemption, Period Two [Member] | ||||
Debt Instrument [Line Items] | ||||
Principal prepayment | 20.00% | |||
Convertible Debt [Member] | Debt Instrument, Redemption, Period Three [Member] | ||||
Debt Instrument [Line Items] | ||||
Principal prepayment | 15.00% | |||
Convertible Debt [Member] | Debt Instrument, Redemption, Period Four [Member] | ||||
Debt Instrument [Line Items] | ||||
Principal prepayment | 10.00% | |||
Promissory Notes [Member] | Unsecured Debt [Member] | Sterne, Kessler, Goldstein & Fox, PLLC [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt | $ 700,000 | |||
Interest rate | 4.00% | |||
Debt payment per month | $ 10,000 | |||
Final balloon payment | $ 590,000 | |||
Subsequent Event [Member] | Convertible Debt [Member] | ||||
Debt Instrument [Line Items] | ||||
Interest rate | 8.00% | |||
Proceeds from debt | $ 300,000 | |||
Conversion price | $ / shares | $ 0.13 | |||
Debt, term | 5 years | |||
Minimum [Member] | Contingent Payment Obligation [Member] | ||||
Debt Instrument [Line Items] | ||||
Percentage of proceeds payment | 52.00% | |||
Maximum [Member] | Contingent Payment Obligation [Member] | ||||
Debt Instrument [Line Items] | ||||
Percentage of proceeds payment | 100.00% | |||
Significant Other Observable Inputs (Level 2) [Member] | Convertible Debt [Member] | ||||
Debt Instrument [Line Items] | ||||
Fair value of note payable | $ 2,300,000 |
Debt (Schedule Of Convertible N
Debt (Schedule Of Convertible Notes Payable) (Details) - USD ($) $ / shares in Units, $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Instrument [Line Items] | ||
Convertible notes, net | $ 2,870 | $ 2,895 |
Convertible Notes Dated January 8, 2020 [Member] | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | |
Convertible Debt [Member] | ||
Debt Instrument [Line Items] | ||
Total principal balance | $ 2,870 | 2,895 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |
Convertible Debt [Member] | Convertible Notes Dated September 10, 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.40 | |
Effective Interest Rate | 8.00% | |
Total principal balance | $ 200 | 200 |
Convertible Debt [Member] | Convertible Note Dated September 19, 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.57 | |
Effective Interest Rate | 8.00% | |
Total principal balance | $ 425 | 425 |
Convertible Debt [Member] | Convertible Notes Dated February/March 2019 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.25 | |
Effective Interest Rate | 8.00% | |
Total principal balance | $ 750 | 750 |
Convertible Debt [Member] | Convertible Note Dated June/July 2019 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.10 | |
Effective Interest Rate | 8.00% | |
Total principal balance | $ 295 | 320 |
Convertible Debt [Member] | Convertible Note Dated July 18, 2019 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.08 | |
Effective Interest Rate | 7.50% | |
Total principal balance | $ 700 | 700 |
Convertible Debt [Member] | Convertible Note Dated September 13, 2019 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.10 | |
Effective Interest Rate | 8.00% | |
Total principal balance | $ 50 | 50 |
Convertible Debt [Member] | Convertible Notes Dated January 8, 2020 [Member] | ||
Debt Instrument [Line Items] | ||
Fixed Conversion Rate | $ 0.13 | |
Effective Interest Rate | 8.00% | |
Total principal balance | $ 450 | $ 450 |
Debt (Reconciliation Of Secured
Debt (Reconciliation Of Secured And Unsecured Contingent Obligation At Fair Value) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Secured Debt [Abstract] | ||
Secured contingent payment obligation | $ 37,372 | |
Secured contingent payment obligation | 36,212 | $ 37,372 |
Contingent Payment Obligation [Member] | Unsecured Debt [Member] | ||
Secured Debt [Abstract] | ||
Change in fair value | (1,142) | 57 |
Unsecured Debt [Abstract] | ||
Unsecured contingent payment obligation | 5,691 | 5,222 |
Issuance of contingent payment rights | 412 | |
Change in fair value | (1,142) | 57 |
Unsecured contingent payment obligation | 4,549 | 5,691 |
Contingent Payment Obligation [Member] | Secured Debt [Member] | ||
Secured Debt [Abstract] | ||
Secured contingent payment obligation | 37,372 | 33,057 |
Change in fair value | (1,160) | 4,315 |
Secured contingent payment obligation | 36,212 | 37,372 |
Unsecured Debt [Abstract] | ||
Change in fair value | $ (1,160) | $ 4,315 |
Fair Value Measurements (Narrat
Fair Value Measurements (Narrative) (Details) - Secured Debt [Member] | Mar. 31, 2022item |
Measurement Input, Discount Rate [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Measurement input | 0.1636 |
Measurement Input, Risk Free Interest Rate [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Measurement input | 0.0236 |
Measurement Input, Entity Credit Risk [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Measurement input | 0.08 |
Measurement Input, Litigation Inherent Risk [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Measurement input | 0.06 |
Fair Value Measurements (Schedu
Fair Value Measurements (Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Secured Contingent Payment Obligation [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | $ 36,212 | $ 37,372 |
Unsecured Contingent Payment Obligation [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 4,549 | 5,691 |
Significant Unobservable Inputs (Level 3) [Member] | Secured Contingent Payment Obligation [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 36,212 | 37,372 |
Significant Unobservable Inputs (Level 3) [Member] | Unsecured Contingent Payment Obligation [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | $ 4,549 | $ 5,691 |
Fair Value Measurements (Quanti
Fair Value Measurements (Quantitative Information) (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2022USD ($)item | |
Unsecured Debt [Member] | Minimum [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated cash outflows | $ | $ 0 |
Duration | 1 year 6 months |
Unsecured Debt [Member] | Minimum [Member] | Estimated Probabilities [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated probabilities | item | 0.05 |
Unsecured Debt [Member] | Weighted Average [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated cash outflows | $ | $ 7.5 |
Duration | 3 years |
Unsecured Debt [Member] | Weighted Average [Member] | Estimated Probabilities [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated probabilities | item | 0.18 |
Unsecured Debt [Member] | Maximum [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated cash outflows | $ | $ 10.8 |
Duration | 3 years 6 months |
Unsecured Debt [Member] | Maximum [Member] | Estimated Probabilities [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated probabilities | item | 0.35 |
Secured Debt [Member] | Minimum [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated cash outflows | $ | $ 0 |
Duration | 1 year 6 months |
Secured Debt [Member] | Minimum [Member] | Estimated Probabilities [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated probabilities | item | 0.05 |
Secured Debt [Member] | Weighted Average [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated cash outflows | $ | $ 59.4 |
Duration | 2 years 10 months 24 days |
Secured Debt [Member] | Weighted Average [Member] | Estimated Probabilities [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated probabilities | item | 0.17 |
Secured Debt [Member] | Maximum [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated cash outflows | $ | $ 88.4 |
Duration | 3 years 6 months |
Secured Debt [Member] | Maximum [Member] | Estimated Probabilities [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Estimated probabilities | item | 0.35 |
Legal Proceedings (Details)
Legal Proceedings (Details) $ in Billions | 1 Months Ended | ||||||||||||
Feb. 28, 2022item | Dec. 31, 2021item | Nov. 30, 2021item | Oct. 31, 2020USD ($) | Jul. 31, 2020item | Jun. 30, 2020item | May 31, 2020item | Apr. 30, 2020claim | Feb. 29, 2020item | Jul. 31, 2019itemclaim | Mar. 31, 2018claim | Mar. 31, 2017claim | Dec. 31, 2015claim | |
Commitments and Contingencies [Line Items] | |||||||||||||
Gain contingency, damages sought | $ | $ 1.3 | ||||||||||||
Number of patents allegedly infringed upon | 4 | ||||||||||||
Number of patents with motion to dismiss | 3 | ||||||||||||
ParkerVision v. LG Electronics [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Additional number of patents subject to Inter Parter review | item | 2 | ||||||||||||
ParkerVision v. Apple and Qualcomm (Middle District of Florida) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Number of patents allegedly infringed upon | 4 | ||||||||||||
Claim construction | item | 2 | ||||||||||||
ParkerVision V. Intel (Western District of Texas) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Number of patents allegedly infringed upon | item | 2 | 8 | |||||||||||
Number of asserted patents | item | 6 | ||||||||||||
ParkerVision v. Intel II (Western District of Texas) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Number of patents allegedly infringed upon | item | 2 | ||||||||||||
Number of patents found not infringed upon | item | 1 | ||||||||||||
ParkerVision v. Qualcomm (Middle District of Florida) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Number of patents allegedly infringed upon | 6 | ||||||||||||
Gain Contingency, Patents Found Infringed upon, Number | 3 | ||||||||||||
Number of patents allegedly infringed upon seeking invalidation | 4 | ||||||||||||
Number of patents with split decision | 2 | ||||||||||||
Claim construction | 7 | ||||||||||||
TCL, et. al. v. ParkerVision (PTAB) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Number of patents subject to Inter Partes review | item | 2 | ||||||||||||
Maximum [Member] | ParkerVision v. Apple and Qualcomm (Middle District of Florida) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Claim construction | item | 6 | ||||||||||||
Maximum [Member] | ParkerVision v. Qualcomm (Middle District of Florida) [Member] | |||||||||||||
Commitments and Contingencies [Line Items] | |||||||||||||
Claim construction | 10 |
Stock Authorization and Issua_2
Stock Authorization and Issuance (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Stock Authorization And Issuance [Line Items] | |||
Common stock, shares authorized | 150,000 | 150,000 | |
Outstanding warrants | 10,300 | ||
Estimated fair market value | $ 3,200 | ||
Weighted Average [Member] | |||
Stock Authorization And Issuance [Line Items] | |||
Warrant term | 2 years 9 months 18 days | ||
Exercise price per warrant | $ 0.75 | ||
Contingent Payment Obligation [Member] | Unsecured Debt [Member] | |||
Stock Authorization And Issuance [Line Items] | |||
Unsecured Debt | $ 4,549 | $ 5,691 | $ 5,222 |
Share-Based Compensation (Detai
Share-Based Compensation (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Share-Based Compensation [Abstract] | ||
Unrecognized compensation cost, net of estimated forfeitures | $ 2,200 | |
Expected weighted average period to recognize the compensation cost, in years | 9 months | |
Total share-based expense | $ 750 | $ 950 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands | May 09, 2022 | Mar. 31, 2022 |
Subsequent Event [Member] | ||
Subsequent Event [Line Items] | ||
Liquidation Dames | 1.00% | |
Convertible Debt [Member] | ||
Subsequent Event [Line Items] | ||
Term | 5 years | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |
Convertible Debt [Member] | Subsequent Event [Member] | ||
Subsequent Event [Line Items] | ||
Proceeds from debt | $ 300 | |
Term | 5 years | |
Debt Instrument, Convertible, Conversion Price | $ 0.13 | |
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |
Maximum [Member] | Subsequent Event [Member] | ||
Subsequent Event [Line Items] | ||
Liquidation Dames | 6.00% | |
Liquidation Dames, Value | $ 20 |